A Phase 1 Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS 9411 in Subjects With Cystic Fibrosis (CF)

NCT01025713 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Development program terminated.

Conditions

Cystic Fibrosis
Mucociliary Clearance

Interventions

DRUG: GS-9411
DRUG: Placebo

Sponsor

Gilead Sciences